|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-6-25
|
|
pubmed:abstractText |
Recent atrial fibrillation guidelines recommend the incorporation of patient preferences into the selection of antithrombotic therapy. However, no trial has examined how incorporating such preferences would affect quality-adjusted survival or medical expenditure. We compared 10-year projections of quality-adjusted survival and medical expenditure associated with two atrial fibrillation treatment strategies: warfarin-for-all therapy versus preference-based therapy. The preference-based strategy prescribed whichever antithrombotic therapy, warfarin or aspirin, had the greater projected quality-adjusted survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0039-2499
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1083-91
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9626276-Aged,
pubmed-meshheading:9626276-Anticoagulants,
pubmed-meshheading:9626276-Aspirin,
pubmed-meshheading:9626276-Atrial Fibrillation,
pubmed-meshheading:9626276-Cerebrovascular Disorders,
pubmed-meshheading:9626276-Cohort Studies,
pubmed-meshheading:9626276-Cost-Benefit Analysis,
pubmed-meshheading:9626276-Decision Trees,
pubmed-meshheading:9626276-Embolism,
pubmed-meshheading:9626276-Female,
pubmed-meshheading:9626276-Health Care Costs,
pubmed-meshheading:9626276-Humans,
pubmed-meshheading:9626276-Male,
pubmed-meshheading:9626276-Middle Aged,
pubmed-meshheading:9626276-Patient Satisfaction,
pubmed-meshheading:9626276-Platelet Aggregation Inhibitors,
pubmed-meshheading:9626276-Quality-Adjusted Life Years,
pubmed-meshheading:9626276-Risk Factors,
pubmed-meshheading:9626276-Sensitivity and Specificity,
pubmed-meshheading:9626276-Thrombolytic Therapy,
pubmed-meshheading:9626276-Warfarin
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation.
|
|
pubmed:affiliation |
Division of General Medical Sciences, Washington University, St Louis, Mo., USA. gage@osler.wustl.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
